Mehra Anand (CIK 0001590102)

Latest company ownership

NXTC - NextCure, Inc.
Role: 10% Owner
Shares held
2,671,856
Last filed at
Nov 19, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
ATYR - aTYR PHARMA INC
Role: 10% Owner
Shares held
1,546,126
Last filed at
May 14, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
SYBX - SYNLOGIC, INC.
Role: 10% Owner
Shares held
583,559
Last filed at
Oct 6, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
Shares held
535,869
Last filed at
Nov 12, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
229,660
Last filed at
May 30, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
OCGN - Ocugen, Inc.
Role: 10% Owner
Shares held
14,569
Last filed at
Dec 10, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4
Shares held
4,793
Last filed at
Jun 9, 2025
Confidence Score
50.1
2025Q4
Confidence Score History
2015Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 19, 2024 Nov 20, 2024 Aclaris Therapeutics, Inc. Director Buy 100.0 +666,666 1537.37% ✗ $1.5M
Nov 15, 2019 Nov 19, 2019 NextCure, Inc. 10% Owner Buy 96.3 +150,000 5.95% ✗ $5.5M
Nov 12, 2019 Nov 12, 2019 Galera Therapeutics, Inc. 10% Owner Buy 100.0 +750,000 32.14% ✗ $9M
May 13, 2019 May 15, 2019 NextCure, Inc. 10% Owner Buy 100.0 +400,000 18.85% ✗ $6M
Oct 22, 2018 Oct 23, 2018 Aclaris Therapeutics, Inc. Director Buy 100.0 +372,093 24.17% ✗ $4M
May 30, 2018 May 30, 2018 Iterum Therapeutics plc 10% Owner Buy 100.0 +500,000 40.77% ✗ $6.5M
Jan 10, 2017 Jan 12, 2017 Aclaris Therapeutics, Inc. Director Sell 15.0 -750,000 -32.76% ✗ $21.2M
Oct 13, 2015 Oct 13, 2015 Aclaris Therapeutics, Inc. Director Buy 100.0 +409,090 21.76% ✗ $4.5M
Oct 5, 2015 Oct 6, 2015 SYNLOGIC, INC. 10% Owner Buy 100.0 +1,146,983 62.75% ✗ $6M
May 12, 2015 May 14, 2015 aTYR PHARMA INC 10% Owner Buy 100.0 +320,000 20.70% ✗ $4.5M
Dec 8, 2014 Dec 10, 2014 Ocugen, Inc. 10% Owner Buy 100.0 +490,388 30.91% ✗ $5.5M